Caxton Associates LLP Makes New Investment in Axsome Therapeutics, Inc. $AXSM
MarketBeat
Caxton Associates LLP bought a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 4,311 shares of the company's stock, valued at approximately $729,000. Other hed
NASDAQ:AXSM